# Kriya Therapeutics funding rounds and investors

As of 14 Oct 2026, Kriya Therapeutics has raised $320M across 1 verified round on record; latest: $320m Series D led by Patient Square Capital and Premji Invest, announced 11 Sep 2025.

Kriya Therapeutics develops durable medicines aimed at treating chronic diseases with one-time administration.

Website: https://kriyatx.com  
Page: https://fireround.dev/companies/kriyatx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-09-11 | Series D | $320m | Patient Square Capital, Premji Invest | Narya, Peter Thiel, The T1D Fund: A Breakthrough T1D Venture | [pharmaceutical-technology.com](https://www.pharmaceutical-technology.com/news/kriya-therapeutics-gene-therapy/?cf-view) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.